A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer
about
A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
A Randomized Phase II Study Of ...... eceptor Positive Breast Cancer
@en
A Randomized Phase II Study Of ...... eceptor Positive Breast Cancer
@nl
type
label
A Randomized Phase II Study Of ...... eceptor Positive Breast Cancer
@en
A Randomized Phase II Study Of ...... eceptor Positive Breast Cancer
@nl
prefLabel
A Randomized Phase II Study Of ...... eceptor Positive Breast Cancer
@en
A Randomized Phase II Study Of ...... eceptor Positive Breast Cancer
@nl
P6153
P1050
P3098
NCT03051659